Thursday, May 23, 2013 Last update: 9:04 PM
Company Tech News as it Breaks
Terumo BCT
News articles for Terumo BCT:
Tuesday, April 9, 2013
- FDA Clears the Terumo BCT Trima Accel® Automated Blood Collection System for the Collection and Storage of Platelets in PASTerumo BCT has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to collect platelets on the Trima Accel system for storage in Isoplate platelet additive ... read more
Wednesday, March 20, 2013
- Terumo BCT Acquires MedserviceTerumo BCT has acquired Medservice, a leading distributor of medical products and services to blood banks and hospitals in Poland. ... read more
Tuesday, February 12, 2013
- Terumo BCT Announces First Patient Enrolled in North American Clinical Trial of Mirasol® Pathogen Reduction Technology SystemTerumo BCT announces that the first patient, in the ongoing PREPAReS (Pathogen Reduction Evaluation & Predictive Analytical Rating Score study) trial, has been enrolled in Canada. Sponsored by ... read more
Tuesday, January 8, 2013
- Terumo BCT to Bestow $100,000 Plasma Exchange Innovation AwardTerumo BCT announces the Call for Expressions of Interest for the Plasma Exchange Innovation Award. This award is designed to fund science and research that furthers greater understanding ... read more
Thursday, January 3, 2013
- Terumo BCT Receives FDA Approval to Conduct an Evaluation of its Polymorphonuclear Cell Collection ProtocolTerumo BCT has received approval from the U.S. Food and Drug Administration (FDA) to conduct a controlled evaluation of the polymorphonuclear (PMN) cell collection protocol on its next-generation ... read more
Tuesday, December 11, 2012
- Terumo BCT Launches New Clinical Trial: Red Blood Cell Exchange in Patients with Sickle Cell Disease Using the Spectra Optia® Apheresis SystemTerumo BCT announces that it has begun a U.S. clinical trial to evaluate the Spectra Optia system’s new Red Blood Cell Exchange (RBCX) Protocol in ... read more